The starting dose and length of time to maintenance dose are critical to optimizing patient tolerability, Blai Coll, chief medical officer of Structure Therapeutics, told BioSpace
Ingredients: aqua/water/eau, dimethicone, stearic acid, glycerin, butylene glycol, glycolic acid, c12-15 alkyl benzoate, pentylene glycol, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, cetearyl alcohol, squalane, sodium hydroxide, dimethicone crosspolymer, ceteareth-20, boron nitride, ammonium acryloyldimethyltaurate/vp copolymer, polysilicone-11, acrylates/c10-30 alkyl acrylate crosspolymer, 1,2-hexanediol, caprylyl glycol, hydroxyacetophenone, polysorbate 60, parfum/fragrance, methylpropanediol, sorbitan isostearate, citrus reticulata (tangerine) peel extract, glucosyl hesperidin, limonene, hyaluronic acid, silanetriol, citric acid, citrus reticulata (tangerine) fruit extract, sodium benzoate, potassium sorbate
10.1007/s10654-017-0255-x Eur J Epidemiol
Secondly, the presence of benzyl alcohol reduces the risk of microorganisms multiplying after the first removal of material from the container